Electrolyte supplementation helps manage some tirzepatide side effects
Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up
for reference, the Wegovy (semaglutide 2.4 mg) UK SmPC advises stopping treatment at least two months before a planned pregnancy
Antifungal exploration of Quinoline derivatives against phytopathogenic fungi inspired by quinine alkaloids
When people desperately want something they cannot easily get, they become more susceptible to products that promise a convenient alternative